Small Business Innovation Research · Small Business Technology Transfer
Novavax, Inc.: SBIR & STTR awards
1 awards worth $246.8K to 1 companies since 2009 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Novavax, Inc.'s federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2009 | 1 | 0 | $246.8K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| Development of a Virus-like Particle (VLP) Vaccine for RSV | Novavax, Inc. · Maryland | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $246.8K | 2009 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.